TransMedics, Inc., a medical technology company dedicated to
improving quality, assessing viability and increasing the
utilization of donor organs for transplantation announced the
closing of $51.2 million growth equity financing.

TransMedics has developed the Organ Care System (OCS"), a
revolutionary first-in-class technology and multi-organ platform
with the potential to improve outcomes for transplant patients and
to dramatically increase the number of transplantable organs
worldwide. The OCS" is the only fully portable technology that
maintains donor organs in a near-physiologic state outside of the
human body and addresses the current limitations of cold
storage.

Some comments from our readers…“The articles are extremely timely and highly applicable”“I often find critical information not available elsewhere”“As in-house counsel, Mondaq’s service is of great value”